Skip to content

Interest Paid at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
$2.16M0.0%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$3.63M
Scholar Rock logo
Scholar RockSRRK
$2.37M+57.9%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$56.45M+0.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$20.32M-12.7%
TG Therapeutics logo
TG TherapeuticsTGTX
$2.39M-61.2%

Other financials

Income statement

See full
Revenue$149.4M+5.6%
Gross profit$134.9M+9.2%
Operating income$73.2M+15.6%
Net income$63.7M+12.3%
EPS (diluted)$0.50+11.1%

Balance sheet

See full
Cash & equivalents$755.9M+30.2%
Total debt$2.7M-13.3%
Total equity$1.0B+27.5%
Total assets$1.1B+26.3%

Cash flow

See full
Operating cash flow$59.6M-0.8%
CapEx$27.0K
Free cash flow$59.6M-0.8%

Valuation

See full
Market cap$3.84B+2.7%

Profitability

See full
Gross margin86%-0.2pp
Operating margin44.8%+1.6pp
Net margin37.1%+0.2pp
FCF margin34.9%-15.2pp

Returns & leverage

See full
Return on equity24.5%-4.6pp
Debt / equity0.0×
Current ratio7.1×+1.0×

Where this comes from

Reported directly by Catalyst Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Catalyst Pharmaceutical's interest paid?
Catalyst Pharmaceutical (CPRX) reported interest paid of $140K in Q1 2026.
How has Catalyst Pharmaceutical's interest paid changed year-over-year?
Catalyst Pharmaceutical's interest paid increased by 35.9% year-over-year, from $103K to $140K.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.